Quantcast

Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.

Research paper by Dixon H DH Xu, Ziwen Z Zhu, Huaping H Xiao, Mark R MR Wakefield, Qian Q Bai, Michael B MB Nicholl, Vivi A VA Ding, Yujiang Y Fang

Indexed on: 04 Mar '17Published on: 04 Mar '17Published in: Cancer Letters



Abstract

Melanoma is the leading cause of death among all skin cancers and its incidence continues to rise rapidly worldwide in the past decades. The available treatment options for melanoma remain limited despite extensive clinical research. Melanoma is an immunogenic tumor and great advances in immunology in recent decades allow for the development of immunotherapeutic agents against melanoma. In recent years, immunotherapy utilizing cytokines has been particularly successful in certain cancers and holds promise for patients with advanced melanoma. In this review, an overview of the current status and emerging perspectives on cytokine immunotherapy for melanoma are discussed in details. Such a study will be helpful to unveil the mysterious mask of cytokine-based immunotherapy for melanoma.